Cutting Edge: Novel Priming of Tumor-Specific Immunity by NKG2D-Triggered NK Cell-Mediated Tumor Rejection and Th1-Independent CD4+ T Cell Pathway1

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Immunology

• Publication date

  2004-01-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.172.2.757PMID 14707044
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biology of Natural Killer Cells

  2008cited by this paper
• CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

  2003cited by this paper
• Tumor and CD4 T-cell interactions: tumor escape as result of reciprocal inactivation.

  2003cited by this paper
• NK Cells Regulate CD4 Responses Prior to Antigen Encounter1

  2003cited by this paper
• Viral infection results in massive CD8+ T cell expansion and mortality in vaccinated perforin-deficient mice.

  2003cited by this paper
• Dendritic Cells Mediate NK Cell Help for Th1 and CTL Responses: Two-Signal Requirement for the Induction of NK Cell Helper Function 1

  2003cited by this paper
• Interleukin-12 and the regulation of innate resistance and adaptive immunity

  2003cited by this paper
• Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help

  2003cited by this paper
• Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

  2003cited by this paper
• NKG2D-DAP10 triggers human NK cell–mediated killing via a Syk-independent regulatory pathway

  2003cited by this paper
• NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases

  2003cited by this paper
• Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis

  2003cited by this paper
• Perforin is required for innate and adaptive immunity induced by heat shock protein gp96.

  2003cited by this paper
• Induction of tumor-specific T cell memory by NK cell–mediated tumor rejection

  2002cited by this paper
• New aspects of natural-killer-cell surveillance and therapy of cancer

  2002cited by this paper
• The role of the NKG2D immunoreceptor in immune cell activation and natural killing.

  2002cited by this paper
• NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation

  2002influential reference
• A Role for IFN-γ in Primary and Secondary Immunity Generated by NK Cell-Sensitive Tumor-Expressing CD80 In Vivo1

  2002cited by this paper
• Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D

  2002influential reference
• Cutting Edge: Tumor Rejection Mediated by NKG2D Receptor-Ligand Interaction Is Dependent upon Perforin1

  2002cited by this paper
• The innate immune response to tumors and its role in the induction of T‐cell immunity

  2002cited by this paper
• NKT cells - conductors of tumor immunity?

  2002cited by this paper
• Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition?

  2002cited by this paper
• Strategies for target cell recognition by natural killer cells

  2001cited by this paper
• Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

  2001cited by this paper
• Natural killer cells, viruses and cancer

  2001cited by this paper
• Human natural killer cell receptors and co‐receptors

  2001cited by this paper
• On guard—activating NK cell receptors

  2001cited by this paper
• Murine natural killer cell activation receptors

  2001cited by this paper
• Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo

  2001cited by this paper
• Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice.

  2000cited by this paper
• Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages

  2000cited by this paper
• Turning on Natural Killer Cells

  2000cited by this paper
• An activating immunoreceptor complex formed by NKG2D and DAP10.

  1999cited by this paper
• CD4 T Cells and Their Role in Antitumor Immune Responses

  1999cited by this paper
• Differential regulation of murine T lymphocyte subsets.

  1993cited by this paper
• Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy

  1986cited by this paper

• The Role of Natural Killer Cells in Oncolytic Virotherapy: Friends or Foes?

  2024cites this paper
• Manipulative-based Activity Using Pop Beads for Demonstration of Sanger Sequencing

  2023cites this paper
• Emerging Concepts on the NKG2D Receptor- NKG2D Ligand Axis in Health and Diseases

  2020cites this paper
• The Paradoxical Role of NKG2D in Cancer Immunity

  2018cites this paper
• Diversification of human NK cells: Lessons from deep profiling

  2018cites this paper
• Tumor Immuno-Environment in Cancer Progression and Therapy.

  2017cites this paper
• Human natural killer cells promote cross‐presentation of tumor cell‐derived antigens by dendritic cells

  2015cites this paper
• Generation of cellular immune memory and B-cell immunity are impaired by natural killer cells

  2015cites this paper
• Boosting vaccine efficacy the natural (killer) way.

  2015cites this paper
• antitumor CTL induction DC-NK cell cross-talk as a novel CD4+ T cell-independent pathway for

  2013cites this paper
• Proteasome inhibition in the regulation of natural killer cell function and multiple myeloma cell apoptosis

  2013cites this paper
• Chapter 9 – Immunological Sculpting: Natural Killer-Cell Receptors and Ligands

  2013cites this paper
• Protective Innate Immune Responses Against Cryptosporidium Parvum

  2013cites this paper
• Anti-tumor and pro-tumor interactions of human NK cells in cancer

  2013cites this paper
• Role of exosomes released by Chronic Myelogenous Leukemia in the modulation of tumor microenvironment

  2012cites this paper
• mTOR kinase inhibitor AZD8055 enhances the immunotherapeutic activity of an agonist CD40 antibody in cancer treatment.

  2011cites this paper
• Helper Activity of Natural Killer Cells During the Dendritic Cell-mediated Induction of Melanoma-specific Cytotoxic T Cells

  2011cites this paper
• Natural killer cells efficiently reject lymphoma silenced for the endoplasmic reticulum aminopeptidase associated with antigen processing.

  2011cites this paper
• Activating and inhibitory receptors of natural killer cells

  2011cites this paper
• The Regulatory Natural Killer Cells

  2010cites this paper
• Requirements for control of B‐cell lymphoma by NK cells

  2010cites this paper
• NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs.

  2009cites this paper
• NK-cell-mediated killing of target cells triggers robust antigen-specific T-cell-mediated and humoral responses.

  2009cites this paper
• Strategies of Natural Killer (NK) Cell Recognition and Their Roles in Tumor Immunosurveillance

  2008cites this paper
• Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice.

  2008cites this paper
• Human Tumor-Derived Exosomes Down-Modulate NKG2D Expression1

  2008cites this paper
• Transcriptional regulation of MICA and MICB: A novel polymorphism in MICB promoter alters transcriptional regulation by Sp1

  2007cites this paper
• Innate tumor immune surveillance.

  2007cites this paper
• Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer

  2007cites this paper
• Cytokine-driven regulation of NK cell functions in tumor immunity: role of the MICA-NKG2D system.

  2007cites this paper
• Immunological Sculpting: Natural Killer Cell Receptors and Ligands

  2007cites this paper
• Current and Future Role of Natural-Killer Cells in Cancer Immunotherapy

  2006cites this paper
• Innate immune recognition and suppression of tumors.

  2006cites this paper
• Hyperthermia and immunity. A brief overview.

  2006cites this paper
• H60/TNT-3 Fusion Protein Activates NK Cells In Vitro and Improves Immunotherapeutic Outcome in Murine Syngeneic Tumor Models

  2006cites this paper
• The regulatory effect of natural killer cells: do "NK-reg cells" exist?

  2006cites this paper
• The role of the NKG2D receptor for tumor immunity.

  2006cites this paper
• Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity.

  2006cites this paper
• The DNA damage response, immunity and cancer.

  2006cites this paper
• Activation and self‐tolerance of natural killer cells

  2006cites this paper
• NK cell receptors as tools in cancer immunotherapy.

  2006cites this paper
• ULBPs, human ligands of the NKG2D receptor, stimulate tumor immunity with enhancement by IL-15.

  2006cites this paper
• Activation of NK cell cytotoxicity.

  2005cites this paper
• Control of murine gammaherpesvirus infection is independent of NK cells

  2005cites this paper
• NK cell recognition.

  2005cites this paper
• NKG2D in NK and T Cell-Mediated Immunity

  2005cites this paper
• Exposure to the electrofusion process can increase the immunogenicity of human cells

  2005cites this paper
• Helper role of NK cells during the induction of anticancer responses by dendritic cells.

  2005cites this paper
• AExpression of MHC Class I-Related Chains Effect of Human Cytomegalovirus on Stastny

  2005cites this paper
• Effect of Human Cytomegalovirus on Expression of MHC Class I-Related Chains A

  2005cites this paper
• Resistance to apoptosis and escape from host immune surveillance - two related (?) survival mechanisms of malignant glioma cells

  2004cites this paper
• Interplay of natural killer cells and their receptors with the adaptive immune response

  2004cites this paper